World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
73
Citations
22110
World Ranking
19601
National Ranking
1767

Adrian C. Newland publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Adrian C. Newland sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 406 publications — 40th percentile

40% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Adrian C. Newland D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Adrian C. Newland sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 73 D-Index — 3rd percentile

3% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Adrian C. Newland is affiliated with Queen Mary University of London in the United Kingdom. Their research primarily spans the field of Medicine, with a strong focus on Hematology, supported by related work in Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging, Genetics, and Immunology.

The main areas of research for Newland revolve around several specific topics including Platelet Disorders and Treatments, Autoimmune Bullous Skin Diseases, Blood groups and transfusion, Monoclonal and Polyclonal Antibodies Research, Chronic Lymphocytic Leukemia Research, Heparin-Induced Thrombocytopenia and Thrombosis, and Glycosylation and Glycoproteins Research.

The scientist has contributed to numerous publications in a variety of notable journals. Frequent publication venues include Blood, Hematology, British Journal of Haematology, Neurology, and The Lancet.

Some of Newland's recent papers include:

  • Practical guidance for the management of adults with immune thrombocytopenia during the COVID-19 pandemic, 2020, British Journal of Haematology
  • Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial, 2023, The Lancet
  • SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP, 2021, Blood
  • Thrombosis in immune thrombocytopenia - current status and future perspectives, 2021, British Journal of Haematology
  • Immune thrombocytopenia, 2021, Expert Review of Hematology

Newland has collaborated frequently with various co-authors throughout their research career. Notable collaborators include:

  • Vickie McDonald
  • Catherine M. Broome
  • David J. Kuter
  • Peter Ulrichts
  • Yoshitaka Miyakawa

Best Publications

  • International consensus report on the investigation and management of primary immune thrombocytopenia.

    Drew Provan;Roberto Stasi;Adrian C. Newland;Victor S. Blanchette

  • Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial

    David J. Kuter;James B. Bussel;Roger M. Lyons;Vinod Pullarkat

  • Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy

    D Provan;A Newland;D Norfolk;P Bolton-Maggs

  • Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review

    Roberto Stasi;Ameet Sarpatwari;Jodi B. Segal;John Osborn

  • Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy.

    David J. Kuter;James B. Bussel;Adrian Newland;Ross I. Baker

  • HIGH-DOSE INTRAVENOUS IgG IN ADULTS WITH AUTOIMMUNE THROMBOCYTOPENIA

    A.C. Newland;J.G. Treleaven;R.M. Minchinton;A.H. Waters

  • Platelets circulate in an activated state in inflammatory bowel disease.

    Carole E. Collins;Mary R. Cahill;Adrian C. Newland;David S. Rampton

  • Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab

    R. Stasi;E. Stipa;G. Del Poeta;S. Amadori

  • Inhibition of autophagy abrogates tumour necrosis factor alpha induced apoptosis in human T-lymphoblastic leukaemic cells.

    Li Jia;Robert R. Dourmashkin;Paul D. Allen;Alan B. Gray

  • Thromboembolic events among adult patients with primary immune thrombocytopenia in the United Kingdom General Practice Research Database

    Ameet Sarpatwari;Dimitri Bennett;John W. Logie;Amit Shukla

  • Efficiency and safety of varying the frequency of whole blood donation (INTERVAL): a randomised trial of 45 000 donors

    Emanuele Di Angelantonio;Simon G Thompson;Stephen Kaptoge;Carmel Moore

  • Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group

    Francesco Rodeghiero;Marc Michel;Terry Gernsheimer;Marco Ruggeri

  • Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma.

    Diana Samson;Adrian Newland;Joseph Kearney;Miles Joyner

  • Treatment of Interstitial Pneumonitis Due to Cytomegalovirus with Ganciclovir and Intravenous Immune Globulin: Experience of European Bone Marrow Transplant Group

    P. Ljungman;D. Engelhard;H. Link;P. Biron

  • Liposomal amphotericin (AmBisome) in the prophylaxis of fungal infections in neutropenic patients: a randomised, double-blind, placebo-controlled study

    SM Kelsey;JM Goldman;S McCann;AC Newland

  • Efficacy of intravenous immunoglobulin in the treatment of autoimmune hemolytic anemia: Results in 73 patients

    Glenn Flores;Charlotte Cunningham‐Rundles;Adrian C. Newland;James B. Bussel

  • The effect of hydroxyethyl starch and other plasma volume substitutes on endothelial cell activation; an in vitro study

    R E Collis;P W Collins;C N Gutteridge;A Kaul

  • An open-label, unit dose-finding study of AMG 531, a novel thrombopoiesis-stimulating peptibody, in patients with immune thrombocytopenic purpura

    Adrian Newland;Marie T. Caulier;Mies Kappers-Klunne;Martin R. Schipperus

  • Guideline for the flow cytometric enumeration of CD34+ haematopoietic stem cellsPREPARED BY THE CD34+ HAEMATOPOIETIC STEM CELL WORKING PARTY*

    D. Barnett;G. Janossy;A. Lubenko;E. Matutes

  • Evaluation of the Anticoagulants EDTA and Citrate, Theophylline, Adenosine, and Dipyridamole (CTAD) for Assessing Platelet Activation on the ADVIA 120 Hematology System

    Marion Macey;Urooj Azam;Desmond McCarthy;Lee Webb

Frequent Co-Authors

Peter Collins
Peter Collins Cardiff University
James B. Bussel
James B. Bussel Cornell University
Sergio Amadori
Sergio Amadori University of Rome Tor Vergata
John G. Gribben
John G. Gribben Queen Mary University of London
Francesco Rodeghiero
Francesco Rodeghiero Yamagata University
Donald Milligan
Donald Milligan University of Birmingham
David C. Linch
David C. Linch University College London
Michael F. Murphy
Michael F. Murphy NHS Blood and Transplant
Douglas B. Cines
Douglas B. Cines University of Pennsylvania
Emad S. Alnemri
Emad S. Alnemri Thomas Jefferson University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens the door to various related online degrees and career pathways in healthcare. One popular option is a health care administration degree, ideal for those who wish to move into leadership and management roles within healthcare organizations. This degree emphasizes skills in healthcare policy, operations, and business strategy.

For registered nurses looking to advance their clinical practice, adn to np bridge programs allow a seamless transition to become a nurse practitioner. These programs are tailored for working professionals, offering flexibility and a clear path for career progression.

Nutrition is another field closely tied to medicine. An online degree in nutrition provides foundational knowledge in dietary science, preparing graduates for roles in education, wellness, and health promotion.

Additionally, earning a leadership credential through online mha programs can equip students with advanced healthcare management skills, qualifying them for upper-level administrative positions in hospitals and health systems.

Best Scientists Citing Adrian C. Newland

Trending Scientists

Recently Published Articles